Borderon J C, Rastegar A, Rolland J C, Laugier J
Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):569-72.
Counts of aerobic fecal pathogens were done using serial dilutions of stools cultured on selective media with or without amoxicillin + clavulanic acid in 15 hospitalized pediatric patients under oral treatment with the association and in 12 non-hospitalized, non-treated controls. Susceptibility was confirmed by disk antibiotic sensitivity testing. The following microorganisms were studied: Enterobacteriaceae, Pseudomonas, Streptococci D, Staphylococci and Candida. In 8 of the 15 treated patients, Enterobacteriaceae were lacking in one sample or more, but subsequent emergence of resistant Enterobacteriaceae during treatment occurred in 4 of these cases. The 7 other treated patients were immediately colonized by resistant Enterobacteriaceae. No resistant Pseudomonas strains emerged. Streptococci D decreased in some cases. No detectable effect on Staphylococci or Candida was found. Enterobacteriaceae resistant to amoxicillin + clavulanic acid were found in 5 of the 12 controls and in 2 cases accounted for the majority of Enterobacteriaceae.
对15名正在接受阿莫西林+克拉维酸联合口服治疗的住院儿科患者以及12名未住院、未接受治疗的对照儿童,采用在添加或未添加阿莫西林+克拉维酸的选择性培养基上培养粪便的系列稀释液,来计数需氧性粪便病原体。通过纸片抗生素敏感性试验确认药敏性。研究了以下微生物:肠杆菌科、假单胞菌属、D群链球菌、葡萄球菌属和念珠菌属。在15名接受治疗的患者中,有8名患者的一个或多个样本中缺乏肠杆菌科,但其中4例在治疗期间出现了耐抗生素肠杆菌科。其他7名接受治疗的患者立即被耐抗生素肠杆菌科定植。未出现耐药假单胞菌菌株。部分病例中D群链球菌数量减少。未发现对葡萄球菌属或念珠菌属有可检测到的影响。在12名对照中有5名发现了对阿莫西林+克拉维酸耐药的肠杆菌科,其中2例中耐药肠杆菌科占肠杆菌科的大多数。